litlas
Log inCreate account

Charles S. Cleeland

Active 1968–2024

Also published as
Charles S Cleeland
180
Papers
50,706
Citations
116
h-index
179
i10-index

Citations

Citations per year for Charles S. Cleeland1976: 1 citations1978: 1 citations1980: 4 citations1981: 1 citations1983: 4 citations1984: 4 citations1985: 14 citations1986: 6 citations1987: 18 citations1988: 9 citations1989: 17 citations1990: 8 citations1991: 23 citations1992: 33 citations1993: 20 citations1994: 39 citations1995: 60 citations1996: 68 citations1997: 50 citations1998: 79 citations1999: 95 citations2000: 161 citations2001: 142 citations2002: 189 citations2003: 208 citations2004: 308 citations2005: 270 citations2006: 299 citations2007: 362 citations2008: 361 citations2009: 409 citations2010: 458 citations2011: 431 citations2012: 357 citations2013: 434 citations2014: 427 citations2015: 407 citations2016: 404 citations2017: 395 citations2018: 356 citations2019: 1,409 citations2020: 1,426 citations2021: 1,283 citations2022: 855 citations2023: 578 citations2024: 1,061 citations2025: 357 citations2026: 12 citations1977: no citations, so this year is not shown1979: no citations, so this year is not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,179 citing papers, 32.2% of this breakdownUnited Kingdom: 1,321 citing papers, 8.2% of this breakdownCanada: 1,032 citing papers, 6.4% of this breakdownGermany: 763 citing papers, 4.7% of this breakdownAustralia: 697 citing papers, 4.3% of this breakdownChina: 663 citing papers, 4.1% of this breakdownNetherlands: 628 citing papers, 3.9% of this breakdownItaly: 539 citing papers, 3.4% of this breakdownFrance: 465 citing papers, 2.9% of this breakdownSpain: 378 citing papers, 2.4% of this breakdownBelgium: 331 citing papers, 2.1% of this breakdownDenmark: 303 citing papers, 1.9% of this breakdown
0%32.2%Other 23.5%

Institutions

Fields

  • Medicine83.8%
  • Psychology3.7%
  • Biochemistry, Genetics and Molecular Biology2.9%
  • Neuroscience2.8%
  • Health Professions2%
  • Economics, Econometrics and Finance1%
  • Other3.8%

Topics

  • Cancer survivorship and care8.1%
  • Pain Management and Opioid Use5.2%
  • Musculoskeletal pain and rehabilitation5%
  • Pain Mechanisms and Treatments3.4%
  • Cancer-related cognitive impairment studies2.7%
  • Pediatric Pain Management Techniques2.6%
  • Other73%

Coauthors

All papers

Open in search
  1. Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

    Authors: Robert H. Dworkin, Dennis C. Turk, Kathleen W. Wyrwich, Dorcas Beaton, Charles S. Cleeland, John T. Farrar, Jennifer A. Haythornthwaite, Mark P. Jensen, Robert D. Kerns, Deborah N. Ader, Nancy A. Brandenburg, Laurie B. Burke, David Cella, Julie Chandler, Penny Cowan, Rozalina Dimitrova, Raymond A. Dionne, Sharon Hertz, Alejandro R. Jadad, Nathaniel P. Katz, Henrik Kehlet, Lynn D. Kramer, Donald C. Manning, Cynthia G. McCormick, Michael McDermott, Henry J McQuay, Sanjay Patel, Linda Porter, Steve Quessy, Bob A. Rappaport, Christine Rauschkolb, Dennis A. Revicki, Margaret Rothman, Kenneth E. Schmader, Brett R. Stacey, Joseph Stauffer, Thorsten von Stein, Richard E. White, James Witter, Stojan Zavisic - Journal of Pain 2007 cited by 3,405

  2. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

    Authors: Dennis C. Turk, Robert H. Dworkin, Robert R. Allen, Nicholas Bellamy, Nancy A. Brandenburg, Daniel B. Carr, Charles S. Cleeland, Raymond A. Dionne, John T. Farrar, Bradley S. Galer, David Hewitt, Alejandro R. Jadad, Nathaniel P. Katz, Lynn D. Kramer, Donald C. Manning, Cynthia G. McCormick, Michael P. McDermott, Patrick J. McGrath, Steve Quessy, Bob A. Rappaport, James P. Robinson, Mike A. Royal, Lee S. Simon, Joseph Stauffer, Wendy M. Stein, Jane Tollett, James Witter - Pain 2003 cited by 3,501

  3. Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Authors: Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell, Steven B. Clauser, Lori M. Minasian, Amylou C. Dueck, Tito R. Mendoza, Jennifer L. Hay, Thomas M. Atkinson, Amy P. Abernethy, Deborah Watkins Bruner, Charles S. Cleeland, Jeff A Sloan, Ram Chilukuri, Paul Baumgartner, Andrea Denicoff, Diane St Germain, Ann M. O’Mara, Alice Chen, Joseph Kelaghan, Antonia V. Bennett, Laura Sit, Lauren J. Rogak, A. Barz, Diane Β. Paul, Deborah Schrag - JNCI Journal of the National Cancer Institute 2014 cited by 1,127

  4. Cancer-Related Fatigue, Version 2.2015

    Authors: Ann M. Berger, Kathi Mooney, Amy Alvarez-Perez, William Breitbart, Kristen M. Carpenter, David Cella, Charles S. Cleeland, Efrat Dotan, Mario A. Eisenberger, Carmen P. Escalante, Paul B. Jacobsen, Catherine M. Jankowski, Thomas W. LeBlanc, Jennifer A. Ligibel, Elizabeth T. Loggers, Belinda N. Mandrell, Barbara A. Murphy, Oxana Palesh, William F. Pirl, Steven C. Plaxe, Michelle B. Riba, Hope S. Rugo, Carolina Salvador, Lynne I. Wagner, Nina D. Wagner‐Johnston, Finly Zachariah, Mary Anne Bergman, Courtney Smith - Journal of the National Comprehensive Cancer Network 2015 cited by 937

  5. Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Authors: Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell, Bryce B. Reeve, Kathleen M. Castro, Lauren J. Rogak, Thomas M. Atkinson, Antonia V. Bennett, Andrea Denicoff, Ann M. O’Mara, Yuelin Li, Steven B. Clauser, Donna Bryant, James D. Bearden, Theresa A. Gillis, Jay K. Harness, Robert D. Siegel, Diane Β. Paul, Charles S. Cleeland, Deborah Schrag, Jeff A. Sloan, Amy P. Abernethy, Deborah Watkins Bruner, Lori M. Minasian, Ethan Basch - JAMA Oncology 2015 cited by 1,015

  6. Assessing symptom distress in cancer patients

    Authors: Charles S. Cleeland, Tito R. Mendoza, Xin Shelley Wang, Chyi Chou, M. Härle, Marilyn Morrissey, Martha C. Engstrom - Cancer 2000 cited by 1,369

  7. Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

    Authors: Robert A. Swarm, Judith A. Paice, Doralina L. Anghelescu, Madhuri Are, Justine Y. Bruce, Sorin Buga, Marcin Chwistek, Charles S. Cleeland, David S. Craig, Ellin Gafford, Heather Greenlee, Eric Hansen, Arif H. Kamal, Mihir Kamdar, Susan B. LeGrand, Sean Mackey, Marc McDowell, Natalie Moryl, Lisle M. Nabell, Suzanne Nesbit, BCPS, Nina O’Connor, Michael W. Rabow, Elizabeth Rickerson, Rebecca Shatsky, Jill E. Sindt, Susan G. Urba, Jeanie Youngwerth, Lydia J. Hammond, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2019 cited by 603

  8. The rapid assessment of fatigue severity in cancer patients

    Authors: Tito R. Mendoza, X. Shelley Wang, Charles S. Cleeland, Marilyn Morrissey, Beth A. Johnson, Judy K. Wendt, Stephen L. Huber - Cancer 1999 cited by 1,775

  9. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

    Authors: Corneel Coens, Madeline Pe, Amylou C. Dueck, Jeff A. Sloan, Ethan Basch, Melanie Calvert, Alicyn Campbell, Charles S. Cleeland, Kim Cocks, Laurence Collette, Nancy Devlin, Lien Dorme, Hans‐Henning Flechtner, Carolyn Gotay, Ingolf Griebsch, Mogens Grøenvold, Madeleine King, Paul G. Kluetz, Michael Koller, Daniel C. Malone, Francesca Martinelli, Sandra A. Mitchell, Jammbe Musoro, Daniel O’Connor, Kathy Oliver, Elisabeth Piault‐Louis, Martine Piccart, Chantal Quinten, Jaap C. Reijneveld, Christoph Schürmann, Ashley Wilder Smith, Katherine M Soltys, Martin Taphoorn, Galina Velikova, Andrew Bottomley - The Lancet Oncology 2020 cited by 306

  10. Validity of the Brief Pain Inventory for Use in Documenting the Outcomes of Patients With Noncancer Pain

    Authors: San Keller, Carla Bann, Sheri Dodd, Jeff Schein, Tito R. Mendoza, Charles S. Cleeland - Clinical Journal of Pain 2004 cited by 1,246

  11. Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain

    Authors: Dennis C. Turk, Robert H. Dworkin, Dennis A. Revicki, Gale Harding, Laurie B. Burke, David Cella, Charles S. Cleeland, Penney Cowan, John T. Farrar, Sharon Hertz, Mitchell B. Max, Bob A. Rappaport - Pain 2007 cited by 525

  12. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

    Authors: Chantal Quinten, Corneel Coens, Murielle Mauer, Sylvie Comte, Mirjam A. G. Sprangers, Charles S. Cleeland, David Osoba, Kristin Bjordal, Andrew Bottomley - The Lancet Oncology 2009 cited by 653

  13. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function

    Authors: Ronald C. Serlin, Tito R. Mendoza, Yoshio Nakamura, Katherine R. Edwards, Charles S. Cleeland - Pain 1995 cited by 1,502

  14. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis

    Authors: Tito R. Mendoza, Tracy J. Mayne, Dale Rublee, Charles S. Cleeland - European Journal of Pain 2005 cited by 441

  15. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

    Authors: Randall L. Daut, Charles S. Cleeland, Randall C. Flanery - Pain 1983 cited by 1,586

  16. The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study

    Authors: Charles S. Cleeland, Fengmin Zhao, Victor T. Chang, Jeff A. Sloan, Ann M. O’Mara, Paul Gilman, Matthias Weiss, Tito R. Mendoza, Ju‐Whei Lee, Michael Fisch - Cancer 2013 cited by 313

  17. Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Authors: Ethan Basch, Claus Becker, Lauren J. Rogak, Deborah Schrag, Bryce B. Reeve, Patricia A. Spears, Mary Lou Smith, Mrinal M. Gounder, Michelle R. Mahoney, Gary K. Schwartz, Antonia V. Bennett, Tito R. Mendoza, Charles S. Cleeland, Jeff A. Sloan, Deborah Watkins Bruner, Gisela Schwab, Thomas M. Atkinson, Gita Thanarajasingam, Monica M. Bertagnolli, Amylou C. Dueck - Clinical Trials 2020 cited by 246

  18. Chinese version of the M. D. Anderson Symptom Inventory

    Authors: Xin Shelley Wang, Ying Wang, Hong Guo, Tito R. Mendoza, Xi‐Shan Hao, Charles S. Cleeland - Cancer 2004 cited by 235

  19. Symptom Burden: Multiple Symptoms and Their Impact as Patient-Reported Outcomes

    Authors: Charles S. Cleeland - JNCI Monographs 2007 cited by 450

  20. Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

    Authors: Charles S. Cleeland, Xin Shelley Wang, Qiuling Shi, Tito R. Mendoza, Sherry L. Wright, Madonna D. Berry, Donna Malveaux, Pankil Shah, Ibrahima Gning, Wayne L. Hofstetter, Joe B. Putnam, Ara A. Vaporciyan - Journal of Clinical Oncology 2011 cited by 351

  21. Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group

    Authors: Claire Piccinin, Ethan Basch, Vishal Bhatnagar, Melanie Calvert, Alicyn Campbell, David Cella, Charles S. Cleeland, Corneel Coens, Anne‐Sophie Darlington, Amylou C. Dueck, Mogens Grøenvold, Ralf Herold, Bellinda L. King‐Kallimanis, Paul G. Kluetz, Dagmara Kuliś, Daniel O’Connor, Kathy Oliver, Madeline Pe, Bryce B. Reeve, Jaap C. Reijneveld, Xin Shelley Wang, Andrew Bottomley - The Lancet Oncology 2023 cited by 68

  22. Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module

    Authors: David I. Rosenthal, Tito R. Mendoza, Mark S. Chambers, Joshua Asper, Ibrahima Gning, Merrill S. Kies, Randal S. Weber, Jan S. Lewin, Adam S. Garden, K. Kian Ang, Xin S. Wang, Charles S. Cleeland - Head & Neck 2007 cited by 314

  23. Pain and Its Treatment in Outpatients with Metastatic Cancer

    Authors: Charles S. Cleeland, René Gonin, Alan K. Hatfield, John H. Edmonson, Ronald H. Blum, James A. Stewart, Kishan J. Pandya - New England Journal of Medicine 1994 cited by 2,021

  24. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)

    Authors: Terri S. Armstrong, Tito R. Mendoza, I. Gring, C. Coco, Marlene Z. Cohen, Lillian R. Eriksen, Ming-Ann Hsu, Mark R. Gilbert, Charles S. Cleeland - Journal of Neuro-Oncology 2006 cited by 272